Navigation Links
Parios Regenerative Sciences, Inc. Licenses Exclusive Rights to Organic Nanotechnology for Skin Repair
Date:11/1/2012

CONCORD, Mass., Nov. 1, 2012 /PRNewswire/ -- Parios Regenerative Sciences, Inc., a privately held medical device company specializing in the development of biomaterials for skin repair and regeneration, has entered into a comprehensive license agreement with Brown University, licensing exclusive rights to a proprietary organic nanotechnology for use in dermatological applications. The nanotechnology, Oderm™, has clinical relevance in cosmetic skin rejuvenation, dermatological applications, and advanced wound care.

"Our agreement with Brown is a significant milestone for Parios," stated Mark Johanson, President and Chief Executive Officer.  "The Oderm™ technology shows great promise in advancing the field of skin regeneration for both aesthetic and wound care applications. We are committed to the commercial and clinical success of this novel skin care product."

Under the terms of the agreement, Parios has obtained an exclusive license to a platform of intellectual property and technologies co-developed by Dr. Thomas Webster, former associate professor of engineering at Brown.

"We are enthusiastic to have partnered with such an experienced and accomplished team at Parios," said Katherine Gordon, Managing Director of the Brown University Technology Ventures Office, "and look forward to successful development of the product."

The Oderm™ biomaterial consists of organic nanomolecules that self-assemble into structures resembling collagen – a major component of skin. Using these organic structures to replace degenerated or damaged skin encourages the growth of natural tissue. The company's goal is to provide off-the-shelf materials that regenerate healthy and functional tissue and offer a repair that lasts the life of the patient.

About Parios Regenerative Sciences, Inc.

Parios is a privately held company located in Concord, MA focused on the growing market of skin tissue regeneration. The company is developing the Oderm™ product line to compete in the non-invasive skin care market, by offering injectable and topical solutions to stimulate collagen regrowth. Current products are in the preclinical phase of development. With Oderm™ and other advanced biomaterials in the pipeline, Parios offers a modern alternative to existing skin repair therapies.


'/>"/>
SOURCE Parios Regenerative Sciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Regado Biosciences, Inc. to Present at the UBS Global Life Sciences Conference 2012 in New York, NY
2. QPS Acquires JSW Life Sciences, Largest Independent Contract Research Organization in Austria
3. Pressure BioSciences, Inc. Reports 70% Revenue Growth for Second Consecutive Quarter
4. Pressure BioSciences, Inc. to Discuss Second Quarter 2012 Financial Results and Provide Business Update
5. Regado Biosciences, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference in Boston, MA
6. Regado Biosciences, Inc. to Present at the 2012 Wedbush PacGrow Life Sciences Conference in New York, NY
7. Founded by Enlight Biosciences, KNODE partners with AstraZeneca and Other Partners
8. KannaLife Sciences, Inc. Signs Exclusive License Agreement with National Institutes of Health Office of Technology Transfer (NIH-OTT)
9. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
10. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
11. West Health Institute licenses Kinect-based physical therapy technology to Reflexion Health; West Health Investment Fund makes $4.25 million investment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... HOUSTON , Dec. 3, 2016   Pairnomix, LLC, ... Precision Medicine Alliance (PEPMA) recognized by the White House, today ... individualized approach to the identification of candidate therapies for a ... SCN8A gene were presented at the 70 th ... in Houston, TX , December 2-6, 2016.  ...
(Date:12/4/2016)... , Dec. 3, 2016  Results from the ... SelG1), an anti-P-selectin antibody, reduced the median annual rate ... to placebo (1.63 vs 2.98, p=0.010) in patients with ... that the data are being featured in the official ... of Hematology (ASH) Annual Meeting and presented during the ...
(Date:12/4/2016)... EAST HANOVER, N.J. , Dec. 3, 2016 ... evaluating efficacy and safety of CTL019, an investigational ... in relapsed/refractory (r/r) pediatric and young adult patients ... presented today during an oral session at the ... (Abstract #221, December 3, 4:00-5:30 p.m.). The global ...
Breaking Medicine Technology:
(Date:12/5/2016)... Diego, CA (PRWEB) , ... December 05, 2016 , ... ... seen and heard the dangers and downsides of patients who do not do their ... The field of cosmetic dermatology is in the midst of a renaissance and every ...
(Date:12/4/2016)... , ... December 02, 2016 , ... ... give patients better access to nutraceuticals and help doctors more efficiently manage their ... portal and practice management software platform for Integrative and Functional Medicine. , ...
(Date:12/4/2016)... TX (PRWEB) , ... December 03, 2016 , ... ... the “Fastest growing Entrepreneurial Company in the Dallas area” Tuesday evening at the ... Omni Dallas Hotel, presented by SMU's Cox School’s Caruth Institute for Entrepreneurship. Dallas ...
(Date:12/2/2016)... California (PRWEB) , ... December 02, 2016 , ... Halfway ... Dental Medicine has provided preventative dental services to more than 15,900 children 5 years ... First 5 LA pledged $38 million over a span of five years to Western ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... Area in Alabama are expected to attend the UNCF Dothan-Wiregrass Mayor’s Luncheon Dec. ... scholarship funds for area students and operating support to UNCF-member institutions, including Miles ...
Breaking Medicine News(10 mins):